Free Trial
OTCMKTS:EKTAY

Elekta Q1 2027 Earnings Results & Report

Elekta logo
$6.14 +0.14 (+2.33%)
As of 03:19 PM Eastern

Elekta reported Q1 2027 earnings on August 27, 2026. The company reported EPS of $0.07, while revenue was $372.30 million.

Earnings Announcement Details

Quarter
Q1 2027
Report Date
Time
Before Market Opens

Elekta EPS Results

Actual EPS
$0.07
Consensus EPS
N/A
Beat/Miss
N/A
One Year Ago EPS
N/A

Elekta Revenue Results

Actual Revenue
$372.30 million
Expected Revenue
N/A
Beat/Miss
N/A
YoY Revenue Growth
N/A

Upcoming Earnings

Elekta's next earnings date is estimated for Wednesday, November 25, 2026, based on past reporting schedules.

Conference Call Resources

Elekta Q1 2027 Earnings FAQ

Elekta (OTCMKTS:EKTAY) reported earnings of $0.07 per share for Q1 2027. The report was announced on Thursday, August 27, 2026.

Elekta reported revenue of $372.30 million for Q1 2027.

Elekta's next earnings date is estimated for Wednesday, November 25, 2026. MarketBeat tracks confirmed and estimated earnings dates for Elekta on the company's earnings history page.

Elekta Earnings Headlines

Elekta (EKTAY) & Its Competitors Critical Contrast
Critical Review: Elekta (OTCMKTS:EKTAY) and SiBone (NASDAQ:SIBN)
Executive Order 14241 Unleashes Trump’s New Dollar
A landmark executive order, 14241, is reportedly set to reshape how Americans use money starting this December. The agenda at the upcoming G20 Summit in Miami has shifted, and new research points to a major monetary announcement from President Trump. A new documentary breaks down what this shift could mean for savings, investments, and the assets tied to it.tc pixel
See More Elekta Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like Elekta? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Elekta and other key companies, straight to your email.

About Elekta

Elekta (OTCMKTS:EKTAY) is a Sweden-based medical technology company that develops and supplies systems and software for radiation therapy, radiosurgery and related cancer-care applications. Its solutions are designed to help hospitals and clinics treat tumors while supporting more precise, personalized and less invasive care.

The company’s portfolio includes linear accelerators, stereotactic radiosurgery systems, magnetic resonance-guided radiation therapy technology and brachytherapy products. Elekta also provides oncology information systems and workflow software, including platforms used for treatment planning, patient management and clinical data coordination.

Founded in 1972 by neurosurgeon and inventor Lars Leksell, Elekta initially focused on radiosurgery and later expanded into broader radiation oncology. The company serves healthcare providers internationally, with operations and customers across Europe, the Americas, Asia and other global markets. Elekta is headquartered in Stockholm, Sweden, and is led by President and Chief Executive Officer Gustaf Salford.

View Elekta Profile